Cumberland Pharmaceuticals Pitch Deck

Summary Balance Sheet 20 ($ IN MILLIONS) CASH & SECURITIES TOTAL ASSETS TOTAL LIABILITIES RETAINED EARNINGS TOTAL EQUITY *$20 million available on revolving line of credit *Tax carry forward credits of $44 million available *Continued Share Repurchase Program Q3 as of Sept 30, 2019 $29.2 103.8 52.1 2.2 51.7

View entire presentation